U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474311) titled 'A Real-World Study of Clinical Use of Available Treatments for Pediatric Patients With Spinal Muscular Atrophy' on March 11.
Brief Summary: The aim of this study was to evaluate real-world treatment patterns and clinical outcomes in pediatric SMA patients in the Czech and Slovak Republics, using data from the Registry of muscular Dystrophy (REaDY).
Study Start Date: Nov. 22, 2011
Study Type: OBSERVATIONAL
Condition:
Muscular Atrophy, Spinal
Recruitment Status: COMPLETED
Sponsor: Novartis Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest....